Cytek Biosciences, Inc.

NasdaqGS:CTKB Stock Report

Market Cap: US$766.4m

Cytek Biosciences Management

Management criteria checks 1/4

Cytek Biosciences' CEO is Wenbin Jiang, appointed in Dec 2014, has a tenure of 9.92 years. total yearly compensation is $4.94M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 4% of the company’s shares, worth $30.68M. The average tenure of the management team and the board of directors is 3.6 years and 2.9 years respectively.

Key information

Wenbin Jiang

Chief executive officer

US$4.9m

Total compensation

CEO salary percentage11.7%
CEO tenure9.9yrs
CEO ownership4.0%
Management average tenure3.6yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Investors Still Aren't Entirely Convinced By Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Despite 46% Price Jump

Nov 07
Investors Still Aren't Entirely Convinced By Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Despite 46% Price Jump

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story

Sep 13
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story

An Intrinsic Calculation For Cytek Biosciences, Inc. (NASDAQ:CTKB) Suggests It's 49% Undervalued

Aug 09
An Intrinsic Calculation For Cytek Biosciences, Inc. (NASDAQ:CTKB) Suggests It's 49% Undervalued

Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?

Jul 12
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?

Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk

Jun 04
Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 20

Cytek Biosciences' (NASDAQ:CTKB) Solid Profits Have Weak Fundamentals

Mar 08
Cytek Biosciences' (NASDAQ:CTKB) Solid Profits Have Weak Fundamentals

Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investments

Jul 27

Checking In On Cytek Biosciences

Mar 23

CEO Compensation Analysis

How has Wenbin Jiang's remuneration changed compared to Cytek Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$10m

Jun 30 2024n/an/a

-US$18m

Mar 31 2024n/an/a

-US$12m

Dec 31 2023US$5mUS$578k

-US$12m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$2m

Dec 31 2022US$4mUS$524k

US$2m

Sep 30 2022n/an/a

-US$901k

Jun 30 2022n/an/a

-US$3m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$5mUS$375k

US$52k

Sep 30 2021n/an/a

US$575k

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$4m

Dec 31 2020US$422kUS$241k

US$3m

Compensation vs Market: Wenbin's total compensation ($USD4.94M) is above average for companies of similar size in the US market ($USD3.22M).

Compensation vs Earnings: Wenbin's compensation has increased whilst the company is unprofitable.

CEO

Wenbin Jiang (60 yo)

9.9yrs

Tenure

US$4,939,242

Compensation

Dr. Wenbin Jiang, Ph D., is co-founder, Chairman and President of Cytek Biosciences, Inc and has been its Chief Executive Officer and Director since December 2014. Dr. Jiang is a seasoned entrepreneur and...

Leadership Team

NamePositionTenureCompensationOwnership
Wenbin Jiang
President9.9yrsUS$4.94m4%
$ 30.7m
Ming Yan
CTO & Director9.8yrsUS$3.07m4.66%
$ 35.7m
Valerie Barnett
Chief Legal Officer & Corporate Secretary3.8yrsUS$1.86m0.042%
$ 320.8k
Allen Poirson
Senior Vice President of Business & Corporate Development3.6yrsUS$1.43m0.044%
$ 338.1k
Patrik Jeanmonod
Head of Corporate Development Analyticsless than a yearUS$1.79m0.076%
$ 580.0k
William McCombe
Chief Financial Officerless than a yearno datano data
Philippe Busque
Senior Vice President of Global Sales & Services1.3yrsno data0.0082%
$ 63.0k

3.6yrs

Average Tenure

60yo

Average Age

Experienced Management: CTKB's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Wenbin Jiang
President9.9yrsUS$4.94m4%
$ 30.7m
Ming Yan
CTO & Director9.8yrsUS$3.07m4.66%
$ 35.7m
Deborah Neff
Independent Director2.4yrsUS$215.67k0%
$ 0
Donnie Hardison
Independent Director2.4yrsUS$217.50k0%
$ 0
Jack Ball
Lead Independent Director6.2yrsUS$260.00k0.021%
$ 160.6k
Michael Holder
Independent Directorless than a yearno data0.0011%
$ 8.7k
Andreas Radbruch
Member of Scientific Advisory Boardno datano datano data
Holden Maecker
Member of Scientific Advisory Boardno datano datano data
Diether J. Recktenwald
Member of Scientific Advisory Boardno datano datano data
Bob Hoffman
Member of Scientific Advisory Boardno datano datano data
Frederic Preffer
Member of Scientific Advisory Boardno datano datano data
Vera Imper
Independent Director2.9yrsUS$215.00k0%
$ 0

2.9yrs

Average Tenure

62yo

Average Age

Experienced Board: CTKB's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.